Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
20
×
Tags
boston blog main
20
×
medical devices
20
×
national blog main
national top stories
biotech
life sciences
texas blog main
boston top stories
san diego blog main
texas top stories
san francisco blog main
san diego top stories
detroit blog main
new york blog main
raleigh-durham blog main
san francisco top stories
seattle blog main
startups
wisconsin blog main
boulder/denver blog main
detroit top stories
fda
indiana blog main
national
new york top stories
raleigh-durham top stories
seattle top stories
wisconsin top stories
venture capital
boulder/denver top stories
indiana top stories
boston
clinical trials
novartis
cancer
deals
funding
investing
ipo
texas
What
bio
life
roundup
medical
device
innovation
new
science
startup
company
devices
houston
investors
therapeutics
better
big
biofourmis
biotechs
black
boston
business
cancer
capital
close
companies
crispr
cyber
data
days
develop
director
drugs
institute
ipo
mammoth
million
patients
takes
texas
they’re
Language
unset
Current search:
photo
×
" medical devices "
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
Roswell, Organovo & More: Xconomy Awards Innovation at the Intersection Finalists
@xconomy.com
5 years ago
Censinet Takes Off With $7.8M to Track Cyber Risks in Healthcare
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
DermaClip Ramps Up for U.S. Sales Push of Wound-Healing Device
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
How a San Antonio Physician Went From a Spy Plane to Olifant Medical
@xconomy.com
5 years ago
TMC’s Halvorsen Exits Innovation Institute in Houston
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion